With the increasing demand for point of care testing, which is estimated to reach 78.3 billion by 2032, and automation in laboratory workflows, there's a growing preference for portable and automated ELISA analyzers.
Portable ELISA analyzers allow for on-site testing in remote or resource-limited settings, enabling rapid diagnosis and timely treatment initiation. Moreover, automated ELISA systems streamline laboratory operations, reducing manual errors, and increasing testing throughput. This enhances efficiency and productivity in healthcare facilities, driving the adoption of ELISA analyzer.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global ELISA analyzers market size was valued at around USD 587.1 million in 2023 and is estimated to grow at 4.2% CAGR from 2024 to 2032, driven by technological advancements in diagnostic testing.
The automated ELISA analyzers segment accounted for USD 352.9 million in 2023 and will expand rapidly through 2032, attributed to the inherent advantages of automation in streamlining the ELISA process and reducing manual intervention.
The U.S. ELISA analyzers market held a decent market share in 2023 and is forecasted to reach USD 305.2 million by 2032, owing to an aging population which is more susceptible to chronic diseases.